Previous Article | Next Article ![]()
J. Virol., Aug 1995, 4924-4932, Vol 69, No. 8
DJ Dargan, AH Patel and JH Subak-Sharpe
Herpes simplex virus (HSV)-infected cells produce not only infectious
nucleocapsid-containing virions but also virion-related noninfectious light
particles (L-particles) composed of the envelope and tegument components of
the virus particle (J. F. Szilagyi and C. Cunningham, J. Gen. Virol.
62:661-668, 1991). We show that BHK and MeWO cells infected either with
wild-type (WT) HSV type 1 (HSV-1) in the presence of viral DNA replication
inhibitors (cytosine-beta-D-arabinofuranoside, phosphonoacetic acid, and
acycloguanosine) or with a viral DNA replication-defective mutant of HSV-1
(ambUL8) synthesize a new type of virus-related particle that is
morphologically similar to an L-particle but differs in its relative
protein composition. These novel particles we term pre-viral DNA
replication enveloped particles (PREPs). The numbers of PREPs released into
the culture medium were of the same order as those of L-particles from
control cultures. The particle/PFU ratios of different PREP stocks ranged
from 6 x 10(5) to 3.8 x 10(8), compared with ratios of 3 x 10(3) to 1 x
10(4) for WT L-particle stocks. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis and Western immunoblot analyses revealed that true late
proteins, such as 273K (VP1-2), 82/81K (VP13/14), and gC (VP8), were
greatly reduced or absent in PREPs and that gD (VP17) and 40K proteins were
also underrepresented. In contrast, the amounts of proteins 175K (VP4;
IE3), 92/91K (VP11/12), 38K (VP22), and gE (with BHK cells) were increased.
The actual protein composition of PREPs showed some cell line-dependent
differences, particularly in the amount of gE. PREPs were biologically
competent and delivered functional Vmw65 (VP16; alpha TIF) to target cells,
but the efficiency of complementation of the HSV-1 (strain 17) mutant
in1814 was 10 to 30% of that of WT L-particles.
Copyright © 1995, American Society for Microbiology
PREPs: herpes simplex virus type 1-specific particles produced by infected cells when viral DNA replication is blocked
Medical Research Council Virology Unit, University of Glasgow, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|